Strategic Trial Design

orange__line

The initial spark that sets off our clinical trial design process is a bright idea that comes to us from the strong mind of a Medical Oncologist. Then, thanks to MedSIR’s innovative set-up, these ideas are transformed into strategic clinical trials that contemplate patient benefit, scientific advance, and efficient drug development.

Today, over 200 ideas now populate our Intellectual Pipeline and involve some of the newest and most impactful drugs on the market -or currently in development- such as pertuzumab, olaparib, niraparib, T-DM1, palbociclib, neratinib, osimertinib, RAD-223, pembrolizumab, atezolizumab, and many more.

A few key factors help us to go from initial idea to the set-up of a successful clinical trial:

1. We understand current and future market trends, which enables us to design coherent and relevant trials not only thinking about today, but also, our patients of tomorrow.

2. Our quick and flexible approach allows us to work efficiently and adapt our trials to your CDPs, company policies and strategies, finding win-win situations for both parties.

3. Our expert team is at the forefront of its domain and strives to draw up the best strategies that are both clinically and scientifically relevant.


«We design our studies synergistically with our clients thanks to sharing a common goal: improving the lives of our patients and their families»


Our continuously growing team of idea generators


  • Jose Perez

    JOSÉ PÉREZ

    Medical Oncologist
    MD, PhD
  • JOAN CARLES

    Medical Oncologist
    MD, PhD
  • David Paez

    DAVID PAEZ

    Medical Oncologist
    MD, PhD
  • NOEMÍ REGUART

    Medical Oncologist
    MD, PhD
  • JOAN MARUEL

    Medical Oncologist
    MD, PhD
  • Josep María Piulats

    JOSEP MARÍA PIULATS

    Medical Oncologist
    MD, PhD
  • Peter Schmid

    PETER SCHMID

    Medical Oncologist
    MD, PhD
  • Esther Holgado

    ESTHER HOLGADO

    Medical Oncologist
    MD, PhD
  • JOSEPH GLIGOROV

    Medical Oncologist
    MD, PhD
  • Frederik Marmé

    FREDERIK MARMÉ

    Gynecologist
    MD, PhD
  • SHAREEF ELSAMANY

    Medical Oncologist
    MD, PhD
  • ANDRÉS POVEDA

    Medical Oncologist
    MD, PhD
  • Niki Karachaliou

    NIKI KARACHALIOU

    Medical Oncologist
    MD, PhD
  • IGNACIO ROMERO

    Medical Oncologist
    MD, PhD
  • JOSÉ ENRIQUE ALÉS

    Medical Oncologist
    MD, PhD
  • ELENA AGUIRRE

    Medical Oncologist
    MD, PhD
  • JAVIER GARDE

    Medical Oncologist
    MD, PhD
Trial_design_light

Since its creation, MedSIR has carried out projects in metastatic breast cancer, endometrial cancer, and lung cancer, while in the process of designing trials for a number of other tumors such as prostate and ovarian. In the near future, the MedSIR concept will allow to expand into other pathologies and diseases.